Evidence map›Paper›PMID 28761324›Full record

ArticleMolecular vision2017

Shunichiro Nakai, Shigeru Honda, Wataru Matsumiya, Akiko Miki, Makoto Nakamura

Abstract read
PubMed Full text at PMC
In one paragraph

Article in Molecular vision, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Genetic Susceptibility, Diet Quality, and Two-Step Progression in Drusen Size.Investigative ophthalmology & visual science · 2020
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shunichiro NakaiDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Shigeru HondaDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Wataru MatsumiyaDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Akiko MikiDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.
Makoto NakamuraDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo determine the association of

methodsThe single nucleotide polymorphism (SNP) at rs10490924 in the

resultsA significant difference was found among the genotypes in the age and the baseline lesion size. The patients with the GG genotype showed a significant improvement in vision, and the patients with the TT genotype showed a significant worsening of vision at all time points measured after the initial PDT. In the multivariate regression analysis, the number of the G allele at rs10490924 was associated with a significantly greater improvement in the baseline best-corrected visual acuity (BCVA) at 36 months after the first PDT.

conclusions

Indexed as

PhotochemotherapyPolymorphism, Single NucleotideAgedFemaleFollow-Up StudiesGenotyping TechniquesHumansMaleProteinsSlit Lamp MicroscopyTomography, Optical CoherenceTreatment OutcomeVisual AcuityWet Macular DegenerationARMS2 protein, humanProteins

Identifiers

PMID28761324
PMCPMC5534487

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.